Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Health Care REITs Industry Analysis

UpdatedMar 16, 2026
DataAggregated Company Financials
Companies18
  • 7D-0.3%
  • 3M8.8%
  • 1Y22.3%
  • YTD10.0%

In the last week, the Health Care REITs industry is flat overall, with Alexandria Real Estate Equities standing out by going down 5.6%. The past year has been better, since the industry has gained 22% in that time. Earnings are forecast to grow by 28% annually.

Industry Valuation and Performance

Has the U.S. Health Care REITs Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 17 Mar 2026US$265.7bUS$32.5bUS$355.1m37.4x748x8.2x
Thu, 12 Feb 2026US$259.3bUS$32.7b-US$426,906,000.0036x-607.3x7.9x
Sat, 10 Jan 2026US$239.8bUS$31.5bUS$440.3m32.4x544.6x7.6x
Mon, 08 Dec 2025US$254.2bUS$31.5bUS$440.3m32.2x577.3x8.1x
Wed, 05 Nov 2025US$234.3bUS$31.8bUS$391.0m29.8x599.3x7.4x
Fri, 03 Oct 2025US$232.6bUS$30.4bUS$354.3m32.1x656.5x7.6x
Sun, 31 Aug 2025US$222.1bUS$30.4bUS$332.7m34.8x667.6x7.3x
Tue, 29 Jul 2025US$209.0bUS$29.4b-US$197,911,000.0033.3x-1055.9x7.1x
Thu, 26 Jun 2025US$200.8bUS$29.4bUS$68.9m36.2x2914.1x6.8x
Sat, 24 May 2025US$192.6bUS$29.7bUS$181.8m31.7x1059x6.5x
Mon, 21 Apr 2025US$197.3bUS$28.7b-US$1,068,162,000.0034.3x-184.7x6.9x
Wed, 19 Mar 2025US$204.8bUS$28.7b-US$1,068,162,000.0035.9x-191.7x7.1x
Fri, 14 Feb 2025US$191.5bUS$28.2b-US$1,397,179,000.0040.2x-137.1x6.8x
Sun, 12 Jan 2025US$172.7bUS$27.4b-US$1,625,663,000.0040.4x-106.2x6.3x
Tue, 10 Dec 2024US$185.0bUS$27.4b-US$1,625,663,000.0043.3x-113.8x6.8x
Thu, 07 Nov 2024US$191.8bUS$27.0b-US$818,734,000.0047.8x-234.2x7.1x
Sat, 05 Oct 2024US$183.6bUS$26.2b-US$1,429,354,000.0054x-128.4x7x
Mon, 02 Sep 2024US$177.6bUS$26.2b-US$1,429,354,000.0052.5x-124.3x6.8x
Wed, 31 Jul 2024US$165.4bUS$26.4b-US$979,140,000.0049.4x-168.9x6.3x
Fri, 28 Jun 2024US$150.4bUS$26.1b-US$1,195,454,000.0043.4x-125.8x5.8x
Sun, 26 May 2024US$127.4bUS$23.1b-US$1,239,464,000.0037.6x-102.8x5.5x
Tue, 23 Apr 2024US$116.7bUS$22.6b-US$276,709,000.0041.9x-421.7x5.2x
Thu, 21 Mar 2024US$115.9bUS$22.5b-US$241,386,000.0041x-480x5.1x
Sat, 17 Feb 2024US$116.6bUS$23.3bUS$226.8m35.4x514.2x5x
Mon, 15 Jan 2024US$117.9bUS$22.9bUS$87.5m47.7x1347.6x5.1x
Wed, 13 Dec 2023US$113.4bUS$22.9bUS$87.5m42.7x1296.5x5x
Fri, 10 Nov 2023US$108.9bUS$22.9bUS$58.8m36.6x1851.4x4.7x
Sun, 08 Oct 2023US$103.0bUS$22.6bUS$502.0m30.7x205.1x4.6x
Tue, 05 Sep 2023US$110.1bUS$22.6bUS$511.5m33.7x215.2x4.9x
Thu, 03 Aug 2023US$115.6bUS$22.3bUS$773.1m33.9x149.5x5.2x
Sat, 01 Jul 2023US$109.5bUS$22.0bUS$785.0m32.6x139.5x5x
Mon, 29 May 2023US$100.8bUS$21.8bUS$840.1m29.4x120x4.6x
Wed, 26 Apr 2023US$103.8bUS$21.2bUS$2.0b31.1x52x4.9x
Price to Earnings Ratio

50.8x


Total Market Cap: US$101.4bTotal Earnings: US$2.0bTotal Revenue: US$21.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Health Care REITs Industry Price to Earnings3Y Average 319.5x202420252026
Current Industry PE
  • Investors are optimistic on the American Health Care REITs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 748x which is higher than its 3-year average PE of 320x.
  • The 3-year average PS ratio of 6.2x is lower than the industry's current PS ratio of 8.2x.
Past Earnings Growth
  • The earnings for companies in the Health Care REITs industry have declined 44% per year over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Real Estate industry?

US Market-2.40%
Real Estate-1.83%
Health Care REITs-0.33%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
WELL WelltowerUS$210.181.2%
+US$1.7b		39.0%PB3.5x
VTR VentasUS$87.791.8%
+US$750.4m		27.7%PB3.3x
AHR American Healthcare REITUS$52.701.0%
+US$95.9m		77.3%PB3x
SBRA Sabra Health Care REITUS$20.911.4%
+US$70.6m		18.7%PB1.9x
CTRE CareTrust REITUS$40.120.6%
+US$51.3m		39.3%PB2.2x

Latest News

CTRE
US$40.12
CareTrust REIT
7D
0.6%
1Y
39.3%
WELL
US$210.18
Welltower
7D
1.2%
1Y
39.0%

Leveraging the Senior Housing Supply Gap

Business Overview Welltower is one of the largest healthcare real estate investment trusts globally, with a market capitalization of approximately US$145 billion. The company owns a diversified portfolio of senior housing communities, outpatient medical facilities and post-acute care properties across the United States, Canada and the United Kingdom.
XRN
US$34.27
Chiron Real Estate
7D
-4.2%
1Y
-22.1%
DOC
US$17.36
Healthpeak Properties
7D
-0.3%
1Y
-15.4%
CHCT
US$16.54
Community Healthcare Trust
7D
-0.5%
1Y
-11.5%
STRW
US$12.82
Strawberry Fields REIT
7D
-0.2%
1Y
2.6%

STRW: Acquisition Pipeline And Peer Discount Will Drive Future Upside

Narrative Update The analyst price target for Strawberry Fields REIT has moved from $14.50 to $16, as analysts point to Q4 results that were ahead of their expectations, continued acquisition driven growth, and what they view as a current discount to comparable healthcare REITs with skilled nursing exposure. Analyst Commentary Recent research updates point to a more constructive stance on Strawberry Fields REIT after its Q4 report, with price targets moving higher and commentary focused on acquisition execution and relative valuation versus other healthcare REITs with skilled nursing exposure.
NHI
US$86.24
National Health Investors
7D
0.7%
1Y
14.2%

NHI: Senior Housing Occupancy Recovery Will Shape Cash Flows And P/E Outlook

Analysts have nudged their fair value estimate for National Health Investors higher, with the target moving from about $85.63 to $88.38. They cite updated assumptions for revenue growth, profit margins, discount rate and future P/E, alongside recent Street research pointing to supportive fundamentals for occupancy in the senior housing portfolio.
OHI
US$47.83
Omega Healthcare Investors
7D
0.2%
1Y
25.1%

OHI: Senior Housing NNN Shift And 2026 Outlook Will Guide Fairly Balanced Setup

Omega Healthcare Investors' analyst price target has moved modestly higher to $49.25 from $48.88 as analysts factor in updated fair value estimates, slightly lower discount rates, and a more constructive view on senior housing growth compared with other healthcare REIT options. Analyst Commentary Recent research updates on Omega Healthcare Investors highlight a mix of optimism around senior housing growth and portfolio repositioning, alongside caution on valuation and medium term guidance.
AHR
US$52.70
American Healthcare REIT
7D
1.0%
1Y
77.3%

AHR: Equity Offerings And Leadership Shift Will Shape Balanced Forward Outlook

Analysts have raised their price target on American Healthcare REIT by about $1.54 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and expected future P/E. What's in the News American Healthcare REIT completed a follow on equity offering totaling about $769.9m across multiple tranches of common stock, including 2,455,858 shares at $40.96, 5,866,000 shares at $42.61, 659,504 shares at $49.217375, and 6,611,272 shares at $48.162553 in an at the market structure (Key Developments).
HR
US$18.15
Healthcare Realty Trust
7D
-1.5%
1Y
8.4%

HR: Buybacks And New Auditor Will Shape Balanced Outlook

Analysts kept their price target for Healthcare Realty Trust steady at $19.40, noting that only minor adjustments to the discount rate, profit margin, and future P/E assumptions contributed to maintaining this view. What's in the News On February 19, 2026, Healthcare Realty Trust’s Audit Committee replaced BDO USA, P.C. with Deloitte & Touche LLP as the company’s independent registered public accounting firm, effective immediately (company filing).
VTR
US$87.79
Ventas
7D
1.8%
1Y
27.7%

VTR: 2026 Earnings Outlook And Dividend Increase Will Support Balanced P/E Expectations

Analysts have nudged their price target on Ventas up by about $1, reflecting slightly adjusted fair value, discount rate, and forward P/E assumptions in their models. What's in the News Ventas issued full year 2026 earnings guidance, projecting net income attributable to common stockholders in a range of $260m to $310m, or $0.52 to $0.62 per share (company guidance).
MPT
US$4.78
Medical Properties Trust
7D
-13.2%
1Y
-20.7%

MPT: Reset Expectations And Execution Risks Will Pressure Cash Flow Resilience

Narrative Update Analysts have updated their price target on Medical Properties Trust to $4.50, citing slightly lower assumed revenue growth, a modestly improved profit margin profile, and a reduced future P/E multiple in their refreshed models. Analyst Commentary Recent research coverage on Medical Properties Trust has been mixed, with at least one firm initiating with a constructive view while other bearish analysts remain focused on execution and valuation risks implied by the updated $4.50 price target.
ARE
US$48.31
Alexandria Real Estate Equities
7D
-5.6%
1Y
-51.5%

ARE: Share Repurchases And Margin Recovery Will Support Future Upside Potential

Analysts have revised their price target on Alexandria Real Estate Equities to $70.00 from $82.97, citing updated assumptions around the discount rate, revenue trends, profit margin, and future P/E expectations. What's in the News Reported real estate impairments of US$1.717b for Q4 2025, compared with US$186.564m in the same quarter a year earlier, highlighting a large adjustment to property values (Key Developments).
SBRA
US$20.91
Sabra Health Care REIT
7D
1.4%
1Y
18.7%

SBRA: External Acquisition Plans And 2026 FFO Guidance Will Shape Balanced Outlook

The analyst price target for Sabra Health Care REIT in our model has shifted modestly higher to $21.69. Analysts point to updated Q4 research that emphasizes near term funds from operations per share support and a preference for external growth through acquisitions.
SILA
US$24.78
Sila Realty Trust
7D
1.5%
1Y
-5.3%